1130223-28-7

Basic information

• Product Name: 4-(4,5,6,7-tetrabromo-2H-1,2,3-benzotriazol-2-yl)butan-1-ol
• Synonyms: 4-(4,5,6,7-tetrabromo-2H-1,2,3-benzotriazol-2-yl)butan-1-ol
• CAS NO: 1130223-28-7
• Molecular Weight: 506.817
• Mol File: 1130223-28-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 4-(4,5,6,7-tetrabromo-2H-1,2,3-benzotriazol-2-yl)butan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4,5,6,7-tetrabromo-2H-1,2,3-benzotriazol-2-yl)butan-1-ol(1130223-28-7)
• EPA Substance Registry System: 4-(4,5,6,7-tetrabromo-2H-1,2,3-benzotriazol-2-yl)butan-1-ol(1130223-28-7)

Safety Data

• Hazardous Substances Data: 1130223-28-7(Hazardous Substances Data)

Upstream product

• 41302-05-0 1-chloro-4-tetrahydropyranyloxybutane 
• 17374-26-4 4,5,6,7-tetrabromobenzotriazole 

Relevant articles and documents

Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide-potential inhibitors of human protein kinase CK2

New derivatives of 4,5,6,7-tetrabromo-1H-1,2,3-benzotriazole (TBBt), 4,5,6,7-tetrabromo-1H-benzimidazole (TBBi), and N-substituted tetrabromophthalimides were synthesized and their effect on the activity of human protein kinase CK2 was examined. The most active were derivatives with N-hydroxypropyl substituents (IC50 in 0.32-0.54 μM range) whereas derivatives of phthalimide were almost ineffective.